No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model

INTRODUCTION: Donepezil is a widely used cholinesterase inhibitor in the management of Alzheimer's disease. Despite large-scaled evidence for its efficacy, elevated peripheral ACh levels often lead to side effects and are dose limiting. The present exploratory study is designed to determine the...

Descripción completa

Detalles Bibliográficos
Autores principales: Baakman, Anne Catrien, Alvarez-Jimenez, Ricardo, Loewen, Gordon, de Kam, Marieke L., Broekhuizen, Karen, Hilt, Dana C., Groeneveld, Geert Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446049/
https://www.ncbi.nlm.nih.gov/pubmed/30984817
http://dx.doi.org/10.1016/j.trci.2019.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446049/
https://www.ncbi.nlm.nih.gov/pubmed/30984817
http://dx.doi.org/10.1016/j.trci.2019.02.002

Ejemplares similares